Novartis acquires AcuStream™ platform, a novel topical ocular delivery device designed to facilitate dosing precision with the potential to support the delivery of front-of-eye therapies and help patient comfort during therapy administration1-3 Acquisition underscores Novartis commitment to deliver innovative, customer- and patient-centric ophthalmic advancements for a range of eye conditions